PTEN and neoplasm: In a treatment study, T2-weighted MRI was used in a genetic mouse model of PTEN-deficient EC to show reduced tumor volume as a result of a synergistic effect to combined treatment with PI3K- (BKM120) and poly (ADP-ribose) polymerase (PARP) inhibitors (Olaparib) (Table 1) [25].